Basis Plan For Postmarketing Survelillances, Etc. Of New Ethical Drugs For Torisel
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Temsirolimus (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 03 Apr 2017 Planned End Date changed from 1 Jun 2015 to 1 Jan 2018.
- 03 Apr 2017 Planned primary completion date changed from 1 Jun 2015 to 1 Jan 2018.
- 03 Apr 2017 Status changed from completed to active, no longer recruiting.